The Brazilian TP53 mutation (R337H) and sarcomas

Sarcomas represent less than 1% of all solid neoplasms in adults and over 20% in children. Their etiology is unclear, but genetic susceptibility plays an important role in this scenario. Sarcoma is central in Li-Fraumeni Syndrome (LFS), a familial predisposition cancer syndrome. In Brazil, the high...

Full description

Saved in:
Bibliographic Details
Published in:PloS one Vol. 15; no. 1; p. e0227260
Main Authors: Volc, Sahlua Miguel, Ramos, Cíntia Regina Niederauer, Galvão, Henrique de Campos Reis, Felicio, Paula Silva, Coelho, Aline Silva, Berardineli, Gustavo Noriz, Campacci, Natalia, Sabato, Cristina da Silva, Abrahao-Machado, Lucas Faria, Santana, Iara Viana Vidigal, Campanella, Nathalia, Lengert, André van Helvoort, Vidal, Daniel Onofre, Reis, Rui Manuel, Dantas, Caio F, Coelho, Robson C, Boldrini, Erica, Serrano, Sergio Vicente, Palmero, Edenir Inêz
Format: Journal Article
Language:English
Published: United States Public Library of Science 01-01-2020
Public Library of Science (PLoS)
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Sarcomas represent less than 1% of all solid neoplasms in adults and over 20% in children. Their etiology is unclear, but genetic susceptibility plays an important role in this scenario. Sarcoma is central in Li-Fraumeni Syndrome (LFS), a familial predisposition cancer syndrome. In Brazil, the high prevalence of p.Arg337His mutations in the TP53 gene brings about a unique condition: a cluster of LFS. In the present work, we studied 502 sarcoma patients not selected by age or family history in an attempt to assess the impact of the so-called "Brazilian germline TP53 mutation" (p.Arg337His) on this tumor type. We found that 8% of patients are carriers, with leiomyosarcoma being the main histologic type of sarcoma, corresponding to 52.5% of the patients with the mutated TP53 gene. These findings emphasize the importance of genetic counseling and can better guide the management of sarcoma patients.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Competing Interests: The authors have declared that no competing interests exist.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0227260